Article Information
History
- February 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lil Meyer-Arndt1,2,3,
- Julian Braun1,4,*,
- Florent Fauchere1,4,*,
- Kanika Vanshylla5,*,
- Lucie Loyal1,4,
- Larissa Henze1,4,
- Beate Kruse1,4,
- Manuela Dingeldey1,4,
- Karsten Jürchott1,4,
- Maike Mangold1,
- Ardit Maraj1,
- Andre Braginets1,
- Chotima Böttcher6,
- Andreas Nitsche7,
- Kathrin de la Rosa8,
- Christoph Ratswohl8,
- Birgit Sawitzki9,
- Pavlo Holenya10,
- Ulf Reimer10,
- Leif E. Sander11,
- Florian Klein5,12,13,
- Friedemann Paul2,14,*,
- Judith Bellmann-Strobl2,14,*,
- Andreas Thiel1,4,*,§ and
- Claudia Giesecke-Thiel16,*,§
- 1Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, 13353 Berlin, Germany
- 2Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, NeuroCure Clinical Research Center, 10117 Berlin, Germany
- 3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neurology with Experimental Neurology, 10117 Berlin, Germany
- 4Si-M / “Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany
- 5Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany
- 6Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, 10117 Berlin, Germany
- 7Robert Koch Institute, 13353 Berlin, Germany
- 8Department of Cancer and Immunology, Max Delbru□ck Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany
- 9Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Immunology, 13353 Berlin, Germany
- 10JPT Peptide Technologies, 12489 Berlin, Germany
- 11Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, 13353 Berlin, Germany
- 12German Center for Infection Research, Partner Site Bonn-Cologne, 50931 Cologne, Germany
- 13Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany
- 14Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Experimental and Clinical Research Center, 13125 Berlin, Germany
- 15Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany
- 16Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany
- ↵§Co-Corresponding authors: Claudia Giesecke-Thiel. Address: Max Planck Institute for Molecular Genetics, Ihnestraße 63, 14195 Berlin, Germany. Phone: 030-8413-1544. Email address: giesecke{at}molgen.mpg.de. Andreas Thiel. Address: Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, 13353 Berlin, Germany. Phone: 030-450-539555. Email address: andreas.thiel{at}charite.de.
↵* equal contribution
Posted February 07, 2022.
SARS-CoV-2 mRNA vaccination fails to elicit humoral and cellular immune responses in multiple sclerosis patients receiving fingolimod
